Transforming Discovery

Empowering Research with AI-Driven Phenotyping

Get Started

Mission

Empowering Biomedical Research

Our company's mission is to empower biomedical research and drug discovery fields with a cutting-edge, fully automated, and scalable high-throughput phenotyping system for animal models and humans.

By harnessing the power of AI and computer vision, our platform allows for the rapid and accurate analysis of vast amounts of phenotyping data, facilitating quicker discovery.

Improving Drug Translation

One of our primary objectives is to significantly improve drug translation from preclinical research to clinical trials. By accurately modeling the effects of potential drugs on various organisms and humans, we aim to streamline the drug development process.

This reduces costs and time-to-market while increasing the likelihood of successful clinical outcomes.

Our Commitment

Together with our community, we are committed to making a positive impact on society by providing a powerful and transformative platform that propels the understanding of life sciences and enhances the translation of innovative drugs for the betterment of human health.

About Us

Minority-Owned

Expertise in Research & Technology

At Tracked Biotechnologies, we're proud to be a minority-owned small business. Our team has extensive experience in both research and information technology, giving us a unique perspective on how to develop innovative solutions.

Artificial Intelligence

Advanced AI algorithms for data analysis and pattern recognition in complex biological systems

Computer Vision

Automated visual analysis for high-throughput screening and phenotypic characterization

Statistical Analysis

Enhanced statistical algorithms for reliable results and meaningful data interpretation

Team

Michael Petr, PhD

Michael Petr, PhD

CEO / Chief Scientist

Expert in aging research, computer vision and biomedical imaging.

Advisors

Alex Zhavoronkov, PhD

Alex Zhavoronkov, PhD

CEO, Insilico Medicine Unpaid

Expert in AI driven drug discovery & robotic labs.

Kennedy Schaal, PhD

Kennedy Schaal, PhD

CEO, Rejuve.bio

Expert in Drosophila and drug discovery.

Contact Us

TRACKED BIOTECHNOLOGIES

Connect with us.

$TrackedBio

CA: 7t1T28iMh5GsW8oTMx52x3u3M3hDbaY8psbL3rZ6BMrn

11100 Endeavor Ct, Suite 137
Manassas, VA 20109

info@trackedbio.com

Loading
Your message has been sent. Thank you!